In this study, we used data from UK Biobank with additional follow‐up time compared to our previous study,8 to clarify the relationships between BMI, ABSI, HI, diabetes, circulating sex steroids, sex steroid binding globulin (SHBG) and prostate cancer risk in men overall and according to BMI categories and diabetes status. Here, SHBG is linked to prostate carcinoma.